Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer. (Q53998437)
scientific article
Language:
Current Data About Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer.
(P31) (Q13442814)
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

(P304) 254-258
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

(P433) 3
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

(P478) 37
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

(P577) Monday, January 1, 1996
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

(P1433) (Q326137)
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

(P1476) "Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer." (language: en)
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

(P2093) K Hoffman
(P1545) 1
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

F A Holmes
(P1545) 2
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

G Fraschini
(P1545) 3
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

L Esparza
(P1545) 4
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

D Frye
(P1545) 5
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

M N Raber
(P1545) 6
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

R A Newman
(P1545) 7
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

G N Hortobagyi
(P1545) 8
(P248)
(P698) 8529286
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/8529286

(P2860) (Q28335713)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

(Q40034426)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

(Q68920718)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

(Q38714808)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

(Q71661629)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

(Q33455539)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

(Q69119820)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

(Q70074094)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

(Q33481203)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

(Q71661635)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/8529286
(P813) Saturday, December 12, 2020
(P887)

other details
description scientific article

External Links
(P356) 10.1007/BF00688325
(P698) 8529286
(P8608) release_szwfdd5dobff3ouxkdif5jof3i